Bob Paulson is the President, CEO & Director of Sonex Health, a privately held medical device company that has developed UltraGuideCTR™ with Meerkat Technology™ to treat carpal tunnel syndrome through a less invasive approach while using real-time ultrasound guidance.  Previously, he was the President, CEO, and a director of the VentureMed Group, a privately-held medical device company that developed and markets the FLEX Vessel Prep™ System to treat peripheral arterial disease and stenoses of arteriovenous fistulas and grafts. From 2009 until its acquisition by Boston Scientific in April of 2018, Bob was president, CEO and a director of NxThera. Bob was president, CEO and a director of Restore Medical from 2005 until the company’s acquisition by Medtronic in July of 2008, and before that, was CFO and vice president of global marketing for Endocardial Solutions, which was acquired by St. Jude Medical in 2005. Bob previously served as senior vice president/general manager of Advanced Bionics, and held several executive positions with Medtronic, including vice president/general manager of the Surgical Navigation Technologies business, vice president, corporate strategy, and director of corporate development. Bob held senior positions in marketing, corporate development, legal and finance at General Mills, and practiced corporate, M&A and securities law with the Minneapolis law firm of Lindquist & Vennum. Bob currently serves on the boards of directors of Veran Medical and Spineology and has been a director of several privately-held and public medical devices companies and charitable foundations. Bob has been a member of the Luther College Board of Regents since 2013, and was elected as vice chair in 2018.